( July 19, 2023, 8:51 AM EDT) -- BOSTON —A Massachusetts federal judge “allowed” the government’s motion for partial summary judgment in its suit alleging that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. violated the False Claims Act (FCA) and Anti-Kickback Statute (AKS) by using co-pay subsidies as kickbacks when selling a multiple sclerosis (MS) drug, finding in part that violating the “AKS is per se material” for claims under the FCA....